Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00151086
Status:
COMPLETED
Last Update Posted:
2015-01-22
First Post:
2005-09-06
Brief Title:
Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
University of Michigan Rogel Cancer Center
Organization Data
Organization:
University of Michigan Rogel Cancer Center
Class:
OTHER
Study ID:
UMCC 2001-050
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Michigan Rogel Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |